---
created: 2025-04-13
updated: 2025-04-13T10:53
id: pLGVmv,nl_
specialty: pulmo
specialty_id: 163
tags:
  - source/ak-original-decks::step-2::cheesy-dorian-(m3)
  - "source/ak-step1-v11:": 
  - source/ome-banner
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::08-respiratory::06-asthma-treatment
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::19-respiratory::albuterol-vs-salmeterol
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::19-respiratory::fluticasone-&-budesonide
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::19-respiratory::montelukast-&-zafirlukast
  - "source/ak-step1-v11:": 
  - theme/uworld::100-999::100-199::169
  - source/ak-step2-v11::!flag-these-cards::potential-duplicates
  - "source/ak-step2-v11::!shelf:": 
  - theme/cards-anking-skipped
  - "source/ak-step2-v11:": 
  - theme/b&b::07-pulmonary::01-pulmonary-disease::02-asthma
  - "source/ak-step2-v11:": 
  - theme/resources-by-rotation::fm::casefiles::wheezing&asthma
  - "source/ak-step2-v11:": 
  - theme/resources-by-rotation::im::emma
  - "source/ak-step2-v11:": 
  - theme/resources-by-rotation::peds::emma
  - "source/ak-step2-v11:": 
  - theme/subjects::pulmonology::05-lungs::obstructive-lung-disease::asthma
  - "source/ak-step2-v11:": 
  - theme/subjects::pulmonology::05-lungs::obstructive-lung-disease::asthma::management-redo
  - source/ak-step2-v11::original-decks::dorian::fam::casefiles::wheezing&asthma
  - source/ak-step2-v11::original-decks::dorian::im::emma
  - source/ak-step2-v11::original-decks::dorian::peds::emma"
type: flashcard
---

# Question
Treatment of Asthma    Intermittent = **SABA** Mild persistent = **SABA** + **ICS** Moderate persistent = **SABA** + **ICS** + **LABA** Severe flare = **SABA** + **ICS** + **LABA** + oral corticosteroids   *Add on leukotriene antagonist (montelukast) at any time

---

# Answer
"SABA: albuterol (short-acting) ICS: inhaled corticosteroid (fluticasone, budesonide) LABA: salmeterol, formoterol (always give with ICS) - ""formation"" and ""salute"" Rule of 2:"